Spirituality and Will to Live in Patients With HIV/AIDS
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00122902|
Recruitment Status : Completed
First Posted : July 22, 2005
Last Update Posted : August 18, 2006
|Condition or disease|
Approximately 1,000,000 Americans have HIV/AIDS. Although advances in treatment have made HIV/AIDS a relatively manageable chronic disease, the disease can cause significant morbidity and mortality. Surprisingly, research has found that some HIV/AIDS patients feel that their life is better than it was before they had HIV/AIDS. Many of these patients show a strong will to live and often express a preference for longevity over quality of life. Patients who prefer longevity often ascribe their feeling to spiritual growth, or finding a meaning to life. This study is examining the spiritual beliefs of HIV/AIDS patients and will determine the relationship between spirituality, health status, and the will to live.
The study consists of interviews with HIV/AIDS patients from Cincinnati and Washington, D.C. who have been interviewed twice over 12 to 18 months. During the interviews, participants completed self-report scales to assess their quality of life, life satisfaction, concerns about medication, trust in their health care providers, depressive symptoms, self-esteem, optimism, and various clinical and demographic variables. Participants were also asked about their spiritual well-being; spiritual beliefs; spiritual, religious, and social support; and overall functioning.
|Study Type :||Observational|
|Enrollment :||350 participants|
|Official Title:||Spirituality and Will to Live in Patients With HIV/AIDS|
|Study Start Date :||February 2002|
|Study Completion Date :||February 2004|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00122902
|United States, Ohio|
|Division of General Internal Medicine, University of Cincinnati Medical Center|
|Cincinnati, Ohio, United States, 45267|
|Principal Investigator:||Joel Tsevat, MD, MPH||Division of General Internal Medicine, University of Cincinnati Medical Center|